Patent · US Active

Capped pyrazinoylguanidine sodium channel blockers

US7868010B2 · kind B2 · utility

36Cited by

25References

15Claims

0Family size

Assignee

Parion Sciences, Inc. · US

Inventors

Michael R. Johnson · Chapel Hill, US
Bruce F. Molino · Slingerlands, US
Jianzhong Zhang · Plano, US
Bruce Sargent · Nottingham, GB

Key dates

Filing date	Mar 17, 2008
Grant date	Jan 11, 2011
Priority date	—
Expiry date	Mar 17, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to substituted pyrazinoylguanidine compounds. These compounds are useful as sodium channel blockers, and may be effective in treating a variety of conditions including chronic bronchitis and cystic fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.